The Editors of Intervirology invite the submission of manuscripts on a wide range of topics in fundamental and medical virology. The journal’s scope encompasses work on the molecular biology of human and animal viruses, including genome organization and regulation, and the structure and function of viral proteins. The pathogenesis, immunology, diagnosis, epidemiology, prophylaxis and therapy of viral diseases are also considered. The journal regularly publishes thematic issues often including timely review articles and field research reports on controversial topics. It aims to be easily accessible to both specialists in the field and to those who want to keep track of the latest developments outside their own area of interest.

Editor-in-Chief
Jean-Claude Manuguerra – Institute Pasteur, Paris, France


Managing Editor
Thomas Labadie – London School of Hygiene & Tropical Medicine, London, UK


Editors
India Leclercq – Institut Pasteur, Paris, France
Délia A. Enria – Instituto de Altos Estudios, Cordoba, Argentina
Rita Catarina Medeiros Sousa – Universidade Federal do Pará, Belém, Brazil 


Associate Editors
Cyril Barbezange – National Institute of Public Health Brussels, Brussels, Belgium
Valery Z. Grdzelishvili – University of North Carolina, Charlotte, NC, USA
Wei-Li Hsu – National Chung-Hsing University, Taichung, Taiwan
Zhihong Hu – Wuhan Institute of Virology, Wuhan, China
Islam Hussein – Microbiotix Inc., Worcester, MA, USA
Karin Moelling – University of Zurich, Zurich, Switzerland
Janusz T. Paweska – National Institute for Communicable Diseases, Johannesburg, South Africa
Wolfgang Preiser – Stellenbosch University and NHLS Tygerberg, Tygerberg, South Africa
Henda Triki – Institut Pasteur, Tunis, Tunisia


Editorial Board Members
Robert D. Burk – Albert Einstein College of Medicine, Bronx, NY, USA
Tony Cunningham – University of Sydney, Westmead, NSW, Australia
Dustin Edwards – Tarleton State University, Stephenville, TX, USA
Okio Hino – Juntendo University, Tokyo, Japan
Joachim Kühn – Universitätsklinikum Münster, Münster, Germany
Uwe Gerd Liebert – Institut für Virologie, Leipzig, Germany
Helene Norder – University of Gothenburg, Gothenburg, Sweden
Carla Osiowy – Public Health Agency of Canada, Winnipeg, MB, Canada
Geoffrey L. Smith – University of Cambridge, Cambridge, UK
Massimo Tommasino – International Agency for Research on Cancer, Lyon, France